These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2694113)

  • 21. Low propensity of conventional antiepileptic drugs for interaction with felbamate against maximal electroshock-induced seizures in mice.
    Borowicz KK; Stasiuk G; Teter J; Kleinrok Z; Gasior M; Czuczwar SJ
    J Neural Transm (Vienna); 2000; 107(7):733-43. PubMed ID: 11005540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Felbamate for partial seizures: results of a controlled clinical trial.
    Leppik IE; Dreifuss FE; Pledger GW; Graves NM; Santilli N; Drury I; Tsay JY; Jacobs MP; Bertram E; Cereghino JJ
    Neurology; 1991 Nov; 41(11):1785-9. PubMed ID: 1944909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy.
    Contin M; Riva R; Albani F; Baruzzi AA
    Ther Drug Monit; 1999 Dec; 21(6):604-8. PubMed ID: 10604819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight loss in patients taking felbamate.
    Bergen DC; Ristanovic RK; Waicosky K; Kanner A; Hoeppner TJ
    Clin Neuropharmacol; 1995 Feb; 18(1):23-7. PubMed ID: 8665531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
    Steinhoff BJ
    Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Felbamate: a new antiepileptic drug.
    Brodie MJ
    Lancet; 1993 Jun; 341(8858):1445-6. PubMed ID: 8099147
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous assay of felbamate plus carbamazepine, phenytoin, and their metabolites by liquid chromatography with mobile phase optimization.
    Remmel RP; Miller SA; Graves NM
    Ther Drug Monit; 1990 Jan; 12(1):90-6. PubMed ID: 2305427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felbamate in epilepsy therapy: evaluating the risks.
    Pellock JM
    Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involuntary movement disorders associated with felbamate.
    Kerrick JM; Kelley BJ; Maister BH; Graves NM; Leppik IE
    Neurology; 1995 Jan; 45(1):185-7. PubMed ID: 7824115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Felbamate increases phenytoin but decreases carbamazepine concentrations.
    Fuerst RH; Graves NM; Leppik IE; Brundage RC; Holmes GB; Remmel RP
    Epilepsia; 1988; 29(4):488-91. PubMed ID: 3391153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of felbamate on the pharmacokinetics of lamotrigine.
    Colucci R; Glue P; Holt B; Banfield C; Reidenberg P; Meehan JW; Pai S; Nomeir A; Lim J; Lin CC; Affrime MB
    J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of felbamate on valproic acid disposition.
    Wagner ML; Graves NM; Leppik IE; Remmel RP; Shumaker RC; Ward DL; Perhach JL
    Clin Pharmacol Ther; 1994 Nov; 56(5):494-502. PubMed ID: 7955813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures.
    Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A
    Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of felbamate on the pharmacokinetics of phenobarbital.
    Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
    Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
    Potschka H; Fedrowitz M; Löscher W
    Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.